Biotech grants in Israel

Closed

Pays three European consortia EUR 15 million each to run generative-AI competitions in aerospace, pharma or telecoms, re-granting up to EUR 2 million per finalist SME team that competes.

Closed

Funds a full-scale plant scaling up fibre-based packaging with new or improved properties, designed from the start for recycling or reuse.

Closed

Funds converting a batch biotech process for making bio-based chemicals or materials into a continuous process with higher productivity and lower cost.

Closed

Pays a university-industry network to build and test new training curricula for bioeconomy skills like biomanufacturing, ecodesign and circularity.

Closed

Awards up to €50,000 to top agrifood and foodtech startups after a hub-based accelerator.

Closed

Funds one consortium to build a certified micro-credentials programme teaching entrepreneurship and innovation to health and life-science students.

Closed

Funds research teams that use gene and epigenome editing to engineer safer, more effective off-the-shelf cell therapies for one chosen disease area.

Closed

Funds bio-based and nature-based remediation projects that clean up polluted soil, sediment and water.

Closed

Pays one coordination team to run the EU-wide policy forum that gets governments, regulators and industry to agree on which animal-testing-alternative methods are ready for official use.

Closed

Funds frontier research by established researchers in Europe-backed programmes across any discipline with high-risk, high-impact ambitions.

Closed

Supports international consortia so small companies can turn joint innovation into export-ready products.

Closed

Funds the coordination of up to ten existing advanced-therapy research centres into one European network, with a shared roadmap for scaling up gene and cell therapy manufacturing.

Closed

Funds a pan-European network of 10-18 startup and scaleup hubs that can pass on up to EUR 60,000 per deep-tech startup for cross-border scaling support.

Closed

Funds small and medium enterprises across Europe via Eurostars Call 11 for collaborative innovation with international partners.

Closed

Funds the next development stage, TRL 5 and up, for regenerative-medicine results that already came out of an earlier, completed EU-funded research project.

Closed

Offers EIT Food's Food Accelerator Network for agrifood startups across Europe to validate and prepare market-ready products.

Closed

Funds consortia that build or adapt generative AI models on large-scale multimodal health data and prove their value with at least two real biomedical use cases.

Closed

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

Closed

Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.

Closed

Funds 4 regional research networks in sub-Saharan Africa to run multi-country clinical trials and rapid outbreak-response research.

Closed

Funds Phase IIa-and-later clinical trials of new or shorter TB drug and chemoprophylaxis regimens for adults and children in sub-Saharan Africa.

Closed

Funds clinical trials of TB vaccine candidates and licensed vaccines targeting adolescents, adults and vulnerable groups in sub-Saharan Africa.

Closed

Funds clinical trials or large-scale implementation research on climate-sensitive water- and vector-borne disease control in sub-Saharan Africa and Europe.

Closed

Funds late-stage clinical trials on treating co-infections and co-morbidities in people living with HIV, not HIV itself, across sub-Saharan Africa.